Angarus Therapeutics
No bio yet
This person is not in any teams
This person is not in any offices
Angarus Therapeutics
Angarus Therapeutics develops immuno-oncology therapies intended to respond to the urgent needs of cancer treatment.The therapy serves as checkpoint blockers on the innate immunity STING pathway, with preclinical data demonstrating that a combination of checkpoint blockers, both innate and adaptive, leads to long term survival, enabling patientswith a wide range of cancer treatments.Chih-Ping Liu established the company in Sunnyvale, California in 2018.